We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
ATTR Amyloidosis: Familial Vs Wild-Type
Noel Dasgupta, MD, FACC
Duchenne Muscular Dystrophy: Differentiating Advances in Treatment
Omer Abdul Hamid, MD
Nancy Kuntz, MD
Migvis Monduy, MD
New Frontiers in Optimizing Patient Outcomes in Multiple Sclerosis: Strategies for Early Intervention to Address Progression Independent of Relapse
Stephen Krieger, MD
Tirisham Gyang, MD
Augusto Miravalle, MD, FAAN
5 Things You Need to Know About Epilepsy & Depression
Heidi M. Munger Clary, MD, MPH
Jay Salpekar, MD, FANPA
Emerging Data in the Management of Intracranial Hemorrhage in the Anticoagulated Patient
W. Brian Gibler, MD, FACEP, FACC, FAHA
Stuart Connolly, MD, FRCPC
Rhonda Cadena, MD, FNCS, FCCM
Greg Albers, MD
Preventing Ischemic Stroke in Today’s World
Mike Sharma, MD, MSc, FRCPC
Emerging Data in the Management of Acute Ischemic Stroke/TIA
Ashkan Shoamanesh, MD
Stroke Management of the Future? The Potential Role of Factor XI/XIa Inhibitors in Secondary Stroke Prevention
Valeria Caso, MD, PhD
Manesh R. Patel, MD
The Path Forward: What’s On the Horizon?
While Antiplatelets Are Good…They Aren’t for Everyone
Optimizing ICH Care By Leveraging AC Reversal, AI & Care Bundling
Natalie Kreitzer, MD, MS
Adrian R. Parry-Jones, FRCP, PhD
ABC-ICH: Does Care Bundling Improve Outcomes for Patients with Intracranial Hemorrhage?
Implementation of the 2022 AHA/ASA Guideline for the Management of Patients with Spontaneous Intracerebral Hemorrhage—Are You Doing Enough?
Providing Optimal Care for the Anticoagulated Patient with Intracranial Hemorrhage in the Acute Care Setting: Does the Patient Need Reversal, Repletion, or Surgery?
The Frontier of Stroke Diagnosis (RapidAI): How Can Artificial Intelligence Improve Acute Care for Ischemic and Hemorrhagic Stroke?
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education